Core Insights - The article discusses the lack of financial planning for long-term care insurance among middle-class families, despite a significant probability of needing such services as individuals age [2][3]. Group 1: Reasons for Lack of Planning - Many middle-class families underestimate the need for long-term care insurance or believe they will not require it [3]. - There is a general lack of awareness about long-term care insurance, with many individuals not knowing its comprehensive coverage options beyond nursing home care [4]. - The perception that long-term care insurance is too expensive deters planning, although even small policies can alleviate financial pressure [5][6]. Group 2: Misconceptions about Coverage - Many individuals mistakenly believe that Medicare will cover most long-term care costs, which is not the case, leading to a false sense of security [7].

Agreement Overview - Eli Lilly has reached an agreement with the Trump Administration to provide its weight loss medication, Zepbound, to Medicare beneficiaries for $50 per month, a significant reduction from the current out-of-pocket cost of $500 per month [3][4] - The agreement also includes a commitment from the Trump Administration to expedite the FDA approval of Eli Lilly's oral GLP-1 medication, orforglipron [19][20] - In return for lower prices, Eli Lilly anticipates increased volume and broader access to its medications [22] Pricing and Access - The $50 per month price point will be available to all Medicare beneficiaries [4] - Eli Lilly plans to offer the same pricing to states for Medicaid beneficiaries, of which there are 90 million people [6] - The company also intends to introduce new offers for Zepbound and orforglipron in the private market and ACA plans [7] Manufacturing and Supply - Eli Lilly has invested $27 billion in U S plants and factories and hired tens of thousands of workers to address manufacturing shortages and ensure sufficient supply of its medications [11] - The company is confident in its ability to supply the increased demand resulting from the agreement [11] International Pricing - Eli Lilly acknowledges that Americans have been paying more for medications than people in other wealthy countries [14] - The company has agreed to equalize prices for weight loss medications like Zepbound and for all new medicines going forward [14] - Eli Lilly seeks government support to improve trade terms with European countries, which currently force the company to lower its prices [15][16] Impact and Future Outlook - Eli Lilly estimates that the agreement could benefit 30 to 40 million people in Medicare alone [26] - The company aims to expand access to its weight loss medications to the vast majority of Americans at low out-of-pocket costs [27] - The company believes this deal will significantly address the chronic disease crisis in Medicare [3]

Tonight, President Trump announcing a deal with drug makers Eli Liy and Novo Nordisk aimed at lowering the cost of popular weight loss drugs Zepbound and WGOI. >> This is tremendous savings for >> and also making this announcement about the federal government's role in making those drugs more accessible for patients who meet certain medical criteria. >> Medicare and Medicaid will finally cover the cost of these weight loss drugs for millions of patients suffering from obesity.Later next year, the White Hous ...

The president said it's a triumph for the American patient. Is it. So like most of these are most favored nations deals that Trump is doing with drug companies.You know, we don't know the full the full details of this yet. The basic parameters, you know, are similar to other deals that Trump has done so far with companies like Pfizer or AstraZeneca. This is kind of the obesity drug deal that Trump is doing.They're talking about prices they offered starting for some Medicare patients with certain conditions, ...

the president speaking uh plan news conference to discuss prescription drug prices. We're going to toss to that right now. >> I haven't heard anything.>> Someday maybe it'll come out which will notify you immediately but so far I haven't heard that including the drugs known as zeppound and we goi often called oepic. This is a triumph for American patients that will save lives and improve the health of millions and millions of Americans. Amazing thing. They are amazing.I want to thank Eli Liy CEO David Ricks ...

Government Policy & Healthcare Access - President Trump announces new deals to lower the cost and expand Medicare coverage of certain obesity drugs [1]

President Trump announces new deals that will lower the cost and expand Medicare coverage of certain obesity drugs. https://t.co/h4sMkaBcYg ...

Stock Performance - Eli Lilly and Novo Nordisk shares increased following reports of potential deals with the White House [1] Policy & Regulation - The White House is reportedly negotiating deals with Eli Lilly and Novo Nordisk to lower weight-loss drug prices [1] - The deals are reportedly in exchange for Medicare coverage of these drugs [1]

Healthcare Cost Increases in 2026 - Employer-sponsored healthcare premiums are projected to increase by an average of 65% for employees [2] - Medicare Part B standard monthly premiums could rise by 116% [3] - Affordable Care Act (ACA) insurers may raise premiums by approximately 26% on average [3] - Without renewed enhanced tax subsidies, monthly premium payments for about 22 million ACA participants could double [3] Strategies for Managing Healthcare Costs - Individuals should track their out-of-pocket healthcare costs (co-payments, medical bills, prescriptions, over-the-counter expenses) to estimate future expenses and coverage needs [4] - Evaluate in-network and out-of-network coverage options when choosing a plan [5] - Consider the trade-off between higher premiums with lower deductibles versus lower premiums with higher deductibles [5] - If eligible, take advantage of a Health Savings Account (HSA) [5] - In 2026, individuals can make a tax-deductible HSA contribution of up to $4400 for themselves or $8750 for their family [6] ACA Plan Considerations - Healthy individuals in the ACA network should consider a bronze plan for emergency coverage, offering the lowest premium but higher out-of-pocket expenses and deductibles [9] - Individuals with minor chronic illnesses might consider a bronze plan plus a direct primary care subscription plan [10] - Individuals with serious illnesses should opt for the most comprehensive coverage, such as a gold or platinum plan [11]

Group 1 - The U.S. population is aging rapidly, with projections indicating that by 2050, approximately 82 million Americans will be aged 65 and older, representing about 1 in 4 Americans compared to 1 in 6 today [2] - The increasing number of retirees will place additional strain on Social Security and healthcare systems, leading to potential economic stress as fewer working-age adults support a larger retired population [3] - Social Security is expected to face a significant shortfall by 2033, with the trust fund projected to be depleted, resulting in automatic benefit cuts of about 20% unless reforms are implemented [4] Group 2 - The average life expectancy in the U.S. is projected to reach around 80 years by 2050, necessitating more savings for retirement due to longer retirement periods [6] - Rising life expectancy will likely lead to increased healthcare and long-term care expenses, with a growing demand for assisted living and home healthcare services as the population aged 85 and older expands [7] - The concept of retirement may evolve, with future retirees potentially working longer or transitioning to part-time roles, combining various income sources such as Social Security, investment income, and gig work [8]